Novartis Institutes for BioMedical Research Inc. 13D and 13G filings for Third Harmonic Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-08 4:30 pm Purchase |
2022-12-31 | 13G | Third Harmonic Bio, Inc. THRD |
Novartis Institutes for BioMedical Research Inc. | 2,642,762 6.500% |
2,642,762 (New Position) |
Filing |